Tags:BioTechDevelopmentHealthTechInvestmentLearnMedTechMessangerPlatformProductWebsite
We are a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system, starting with painful diabetic neuropathy, fibromyalgia, PTSD and Parkinson’s cognitive impairment. We have a proven platform for discovering proprietary compounds that works through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Our goal is to rapidly advance our pipeline of novel clinical candidates to treat indications with high unmet medical need. At Aptinyx, we remain committed and responsive to our employees. We offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. If you are interested in learning more about our company or rewarding career opportunities, please visit our website at www.aptinyx.com or follow us on Twitter @Aptinyx
Location: United States, Illinois, Evanston
Member count: 51-200
Total raised: $135M
Founded date: 2015

Investors 11

Show more

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
18.12.2017Series B$70M-finsmes.co...
10.05.2016Series A$65M-vcnewsdail...

Mentions in press and media 30

DateTitleDescriptionCategoryAuthorSource
12.08.2022House pass...In 2019, Aptinyx’s stock crate...-Zachary Br...endpts.com...
12.08.2022Bolt throw...A melt­down in the biotech mar...-Aayushi Pr...endpts.com...
10.11.2021Aptinyx Re...Aptinyx Reports Third Quarter ...--marketscre...
16.09.2021Aptinyx : ...Aptinyx Inc. (Nasdaq: APTX), a...--marketscre...
10.08.2021Aptinyx : ...Initiating CEO transition plan...--marketscre...
10.03.2019Clinical t...The three studies – RAP-MD-01,...--medcitynew...
16.01.2019Aptinyx sh...Aptinyx’s ap­proach to mod­u­l...-Natalie Gr...endpts.com...
03.12.20185 Startup ...2018 is quickly drawing to its...--hpa.vc/5-s...
29.11.20185 startup ...2018 is quickly drawing to its...-Pete Wilki...venturebea...
29.11.20185 startup ...We are excited to bring Transf...-Pete Wilki...venturebea...
Show more